文献速递血栓与止血

COVID-19临床研究中血栓相关数据元素收集工具包

A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies.
PubMed 文献 · Blood Adv · 2020-01-01

美国血液学会研究协作组COVID-19非恶性血液学工作组与国际血栓与止血学会COVID-19工作组合作,针对静脉血栓栓塞、心肌梗死、卒中/短暂性脑缺血发作、外周动脉血栓、出血、实验室检查和抗血栓治疗等领域,制定了3个详细级别的数据元素集,以促进临床研究的标准化数据收集与报告。

要点

  • 血栓是COVID-19重要并发症,尤其重症患者,但发生率因研究设计等因素而异。
  • 工具包涵盖7个领域的数据元素,每个领域分3个详细级别。
  • 标准化变量可提升数据质量、效率及研究间可比性,利于数据合并。

核心结论

  • 标准化数据元素收集有助于提高COVID-19血栓相关临床研究的质量与可比性。

研究设计与样本

  • 由美国血液学会研究协作组COVID-19非恶性血液学工作组与国际血栓与止血学会COVID-19工作组合作制定数据元素集。

主要发现

  • 针对静脉血栓栓塞、心肌梗死、卒中/短暂性脑缺血发作、外周动脉血栓、出血、实验室检查和抗血栓治疗7个领域制定数据元素。
  • 每个领域的数据元素设3个详细级别,便于纳入不同干预与结局的研究。
  • 尽可能纳入已发表的数据元素。

临床怎么用

  • 在临床研究中采用标准化变量可增强数据收集质量、提高效率、促进研究间结果比较并利于未来数据集合并。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thrombosis has emerged as an important complication of coronavirus disease 2019 (COVID-19), particularly among individuals with severe illness. However, the precise incidence of thrombotic events remains uncertain due to differences in study design, patient populations, outcome ascertainment, event definitions, and reporting. In an effort to overcome some of these challenges and promote standardized data collection and reporting in clinical studies, the American Society of Hematology Research Collaborative COVID-19 Non-Malignant Hematology Task Force, in collaboration with the International Society on Thrombosis and Haemostasis COVID-19 Task Force, developed sets of data elements in the following domains: venous thromboembolism, myocardial infarction, stroke/transient ischemic attack, peripheral arterial thrombosis, bleeding, laboratory investigations, and antithrombotic therapy. Data elements in each of these domains were developed with 3 levels of detail to facilitate their incorporation into studies evaluating a range of interventions and outcomes. Previously published data elements were included where possible. The use of standardized variables in a range of clinical studies can enhance the quality of data collection, create efficiency, enhance comparison of results across studies, and facilitate future pooling of data sets.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Siegal DM, Barnes GD, Langlois NJ, et al. A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies. Blood Adv. 2020. PMID: 33351119. doi:10.1182/bloodadvances.2020003269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。